Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Article in English | MEDLINE | ID: mdl-38570274

ABSTRACT

OBJECTIVE: To evaluate the effect of arthroplasty using interpositional cartilage allografts in patients with temporomandibular joint (TMJ) arthrosis. STUDY DESIGN: This retrospective study included patients treated consecutively between 2007 and 2013 using discectomy and interpositional grafting with lyophilized costal cartilage allograft (Tutoplast) sheets. TMJ pain based on the visual analogue scale (VAS), maximal interincisal opening (MIO), joint tenderness to palpation, crepitus from the affected joint, and postoperative complications were assessed. RESULTS: Arthroplasty was performed on 37 joints among 34 patients (28 women; mean age: 54 years); 24 joints underwent simultaneous condyle shaving. At final follow-up (3 [n = 37] or 5 [n = 21] years), we observed reduced mean VAS (from 7.6 to 0.9; P < .001) increased mean MIO (from 32.5 to 41.1 mm; P < .001), number of joints with capsule tenderness (from 30 to 3; P < .001), and percentage of joints with crepitus (from 97% to 75%; P = .008). One joint required reoperation because of interposed cartilage fragmentation. No permanent facial nerve injury or malocclusion occurred after treatment. CONCLUSIONS: Interpositional arthroplasty is a relatively simple, moderately invasive, and effective surgical treatment for TMJ arthrosis with few complications. However, long-term outcomes of this treatment, specifically beyond 3-5 years postoperatively, remain unknown.


Subject(s)
Allografts , Arthroplasty , Temporomandibular Joint Disorders , Humans , Female , Retrospective Studies , Male , Middle Aged , Temporomandibular Joint Disorders/surgery , Follow-Up Studies , Arthroplasty/methods , Treatment Outcome , Adult , Aged , Pain Measurement , Postoperative Complications , Osteoarthritis/surgery , Cartilage/transplantation
2.
ACS Sustain Chem Eng ; 12(1): 178-191, 2024 Jan 08.
Article in English | MEDLINE | ID: mdl-38213546

ABSTRACT

Synthetic polyolefinic plastics comprise one of the largest shares of global plastic waste, which is being targeted for chemical recycling by depolymerization to monomers and small molecules. One promising method of chemical recycling is solid-state depolymerization under ambient conditions in a ball-mill reactor. In this paper, we elucidate kinetic phenomena in the mechanochemical depolymerization of poly(styrene). Styrene is produced in this process at a constant rate and selectivity alongside minor products, including oxygenates like benzaldehyde, via mechanisms analogous to those involved in thermal and oxidative pyrolysis. Continuous monomer removal during reactor operation is critical for avoiding repolymerization, and promoting effects are exhibited by iron surfaces and molecular oxygen. Kinetic independence between depolymerization and molecular weight reduction was observed, despite both processes originating from the same driving force of mechanochemical collisions. Phenomena across multiple length scales are shown to be responsible for differences in reactivity due to differences in grinding parameters and reactant composition.

3.
Nature ; 626(7999): 617-625, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38081298

ABSTRACT

The outer membrane in Gram-negative bacteria consists of an asymmetric phospholipid-lipopolysaccharide bilayer that is densely packed with outer-membrane ß-barrel proteins (OMPs) and lipoproteins1. The architecture and composition of this bilayer is closely monitored and is essential to cell integrity and survival2-4. Here we find that SlyB, a lipoprotein in the PhoPQ stress regulon, forms stable stress-induced complexes with the outer-membrane proteome. SlyB comprises a 10 kDa periplasmic ß-sandwich domain and a glycine zipper domain that forms a transmembrane α-helical hairpin with discrete phospholipid- and lipopolysaccharide-binding sites. After loss in lipid asymmetry, SlyB oligomerizes into ring-shaped transmembrane complexes that encapsulate ß-barrel proteins into lipid nanodomains of variable size. We find that the formation of SlyB nanodomains is essential during lipopolysaccharide destabilization by antimicrobial peptides or acute cation shortage, conditions that result in a loss of OMPs and compromised outer-membrane barrier function in the absence of a functional SlyB. Our data reveal that SlyB is a compartmentalizing transmembrane guard protein that is involved in cell-envelope proteostasis and integrity, and suggest that SlyB represents a larger family of broadly conserved lipoproteins with 2TM glycine zipper domains with the ability to form lipid nanodomains.


Subject(s)
Bacterial Outer Membrane Proteins , Cell Membrane , Gram-Negative Bacteria , Lipid Bilayers , Bacterial Outer Membrane Proteins/chemistry , Bacterial Outer Membrane Proteins/metabolism , Cell Membrane/chemistry , Cell Membrane/metabolism , Glycine/metabolism , Lipopolysaccharides/metabolism , Lipoproteins/chemistry , Lipoproteins/metabolism , Phospholipids/metabolism , Binding Sites , Proteostasis , Lipid Bilayers/chemistry , Lipid Bilayers/metabolism , Proteome/chemistry , Proteome/metabolism , Regulon , Protein Domains , Antimicrobial Peptides/metabolism , Gram-Negative Bacteria/chemistry , Gram-Negative Bacteria/cytology , Gram-Negative Bacteria/metabolism
4.
Nagoya J Med Sci ; 84(1): 19-28, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35392005

ABSTRACT

Evaluation of liver fibrosis is necessary to make the therapeutic decision and assess the prognosis of CHB patients. The current study aimed to describe the progression and identify some influencing factors in patients with chronic hepatitis B at a General Hospital in Northern Vietnam. The longitudinal study included 55 eligible subjects diagnosed Hepatitis-B-virus. Dependent variable was the aspartate aminotransferase/platelet ratio index and we collected some demographic variables and disease related and behaviour variables. Bayesian Model Averaging was used to select variables into model. Mixed-effect linear models were used to evaluate the change of the aspartate aminotransferase/platelet ratio index over time and identify related factors. the aspartate aminotransferase/platelet ratio index differences between examinations, age of participants, working status were statistically significant. This pattern indicated that the average the aspartate aminotransferase/platelet ratio index of the population decreased by 0.005 (95% CI=-0.009; -0.001) after each patient's visit, and increased by 0.013 if the patient's age increased by 1 year (95% CI=0.005; 0.0219). For non-working patients, the aspartate aminotransferase/platelet ratio index was lower, coefficient was -0.054 (95% CI=-0.108; 0.001). Other variables such as gender, education level, time for disease detection, drinking tea, alcohol consumption, forgetting to take medicine and the aspartate aminotransferase/platelet ratio index were not significantly different. The study showed that the majority of study subjects had average the aspartate aminotransferase/platelet ratio index, and were relatively well controlled and treated during the study. Age and working status are factors that influence the the aspartate aminotransferase/platelet ratio index.


Subject(s)
Hepatitis B, Chronic , Aspartate Aminotransferases , Bayes Theorem , Biomarkers , Hepatitis B, Chronic/diagnosis , Hepatitis B, Chronic/drug therapy , Hepatitis B, Chronic/epidemiology , Hospitals, General , Humans , Liver Cirrhosis/epidemiology , Longitudinal Studies , Platelet Count , Retrospective Studies , Severity of Illness Index , Vietnam/epidemiology
5.
Sensors (Basel) ; 22(4)2022 Feb 14.
Article in English | MEDLINE | ID: mdl-35214357

ABSTRACT

This paper comprehensively investigates the performance of the D2D underlaying cellular networks where D2D communications are operated concurrently with cellular networks provided that the aggregate interference measured on licensed users is strictly guaranteed. In particular, we derive the outage probability (OP), the average rate, and the amount of fading (AoF) of the D2D networks in closed-form expressions under three distinct power allocation schemes, i.e., the path-loss-based, equal, and random allocation schemes. It is noted that the considered networks take into consideration the impact of the intra-D2D networks, the inter-interference from the cellular networks and background noise, thus involving many random variables and leading to a complicated mathematical framework. Moreover, we also reveal the behavior of the OP with respect to the transmit power based on the rigorous mathematical frameworks rather than the computer-based simulation results. The derived framework shows that increasing the transmit power is beneficial for the OP of the D2D users. Regarding the cellular networks, the coverage probability (Pcov) of the cellular users is computed in closed-form expression too. Monte Carlo simulations are given to verify the accuracy of the proposed mathematical frameworks. Our findings illustrate that the power allocation method based on prior path-loss information outperforms the other methods in the average sum rate.


Subject(s)
Algorithms , Computer Communication Networks , Computer Simulation , Monte Carlo Method , Probability
7.
PLoS One ; 16(7): e0254232, 2021.
Article in English | MEDLINE | ID: mdl-34214145

ABSTRACT

The type VI secretion system (T6SS) is a widespread mechanism of protein delivery into target cells, present in more than a quarter of all sequenced Gram-negative bacteria. The T6SS constitutes an important virulence factor, as it is responsible for targeting effectors in both prokaryotic and eukaryotic cells. The T6SS comprises a tail structure tethered to the cell envelope via a trans-envelope complex. In most T6SS, the membrane complex is anchored to the cell wall by the TagL accessory protein. In this study, we report the first crystal structure of a peptidoglycan-binding domain of TagL. The fold is conserved with members of the OmpA/Pal/MotB family, and more importantly, the peptidoglycan binding site is conserved. This structure further exemplifies how proteins involved in anchoring to the cell wall for different cellular functions rely on an interaction network with peptidoglycan strictly conserved.


Subject(s)
Bacterial Proteins/metabolism , Cell Wall/metabolism , Peptidoglycan/metabolism , Protein Domains/physiology , Type VI Secretion Systems/metabolism , Gram-Negative Bacteria/metabolism , Virulence Factors/metabolism
8.
Sci Rep ; 11(1): 7788, 2021 Apr 08.
Article in English | MEDLINE | ID: mdl-33833295

ABSTRACT

In this study, we report the segregation of magnesium in the grain boundaries of magnesium-doped cuprous oxide (Cu2O:Mg) thin films as revealed by atom probe tomography and the consequences of the dopant presence on the temperature-dependent Hall effect properties. The incorporation of magnesium as a divalent cation was achieved by aerosol-assisted metal organic chemical vapour deposition, followed by thermal treatments under oxidizing conditions. We observe that, in comparison with intrinsic cuprous oxide, the electronic transport is improved in Cu2O:Mg with a reduction of resistivity to 13.3 ± 0.1 Ω cm, despite the reduction of hole mobility in the doped films, due to higher grain-boundary scattering. The Hall carrier concentration dependence with temperature showed the presence of an acceptor level associated with an ionization energy of 125 ± 9 meV, similar to the energy value of a large size impurity-vacancy complex. Atom probe tomography shows a magnesium incorporation of 5%, which is substantially present at the grain boundaries of the Cu2O.

9.
Nat Chem Biol ; 16(9): 1019-1025, 2020 09.
Article in English | MEDLINE | ID: mdl-32572278

ABSTRACT

The ß-barrel assembly machinery (BAM) inserts outer membrane ß-barrel proteins (OMPs) in the outer membrane of Gram-negative bacteria. In Enterobacteriacea, BAM also mediates export of the stress sensor lipoprotein RcsF to the cell surface by assembling RcsF-OMP complexes. Here, we report the crystal structure of the key BAM component BamA in complex with RcsF. BamA adopts an inward-open conformation, with the lateral gate to the membrane closed. RcsF is lodged deep within the lumen of the BamA barrel, binding regions proposed to undergo outward and lateral opening during OMP insertion. On the basis of our structural and biochemical data, we propose a push-and-pull model for RcsF export following conformational cycling of BamA, and provide a mechanistic explanation for how RcsF uses its interaction with BamA to detect envelope stress. Our data also suggest that the flux of incoming OMP substrates is involved in the control of BAM activity.


Subject(s)
Bacterial Outer Membrane Proteins/chemistry , Bacterial Outer Membrane Proteins/metabolism , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/metabolism , Escherichia coli/chemistry , Escherichia coli/metabolism , Bacterial Outer Membrane Proteins/genetics , Crystallography, X-Ray , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Lipid Bilayers/chemistry , Lipid Bilayers/metabolism , Models, Molecular , Protein Conformation
10.
J Clin Monit Comput ; 34(4): 827-832, 2020 Aug.
Article in English | MEDLINE | ID: mdl-31352626

ABSTRACT

To limit functional surgical failure and reduce the rate of revision surgery in case of surgical ossicular chain reconstruction, a piezoelectric device was developed for assessment of ossicular chain vibrations during the middle ear surgery. The device resembled a pen and consisted of a reusable main body and a disposable sensitive head including piezoelectric polymer sensor. Almost all of components of the device were made of polymer for light weight and for acoustic impedance matching to the middle ear system. Several frequencies can be analyzed simultaneously and several measures can be taken by time. The results showed that the device can record normal and reconstructed ossicular chain vibration in response to an acoustic stimulation, with similar results to those achieved by laser Doppler vibrometer. This light, handheld and low-cost device allows fast, easy and safe assessments of normal ossicular chain mobility and ossicular chain reconstruction efficiency. Primary pre-clinical trial showed very promising performance of the device that could be used to qualitatively control ossiculoplasty during real-time surgical procedure. Clinical assessments will be done to further evaluate the real-life performance of the device.


Subject(s)
Ear Ossicles/surgery , Ear, Middle/surgery , Monitoring, Intraoperative/instrumentation , Acoustic Stimulation , Acoustics , Ear Ossicles/physiopathology , Ear, Middle/physiopathology , Electric Impedance , Equipment Design , Hearing/physiology , Humans , Monitoring, Intraoperative/methods , Polymers , Treatment Outcome , Vibration
11.
J Mol Biol ; 430(24): 5120-5136, 2018 12 07.
Article in English | MEDLINE | ID: mdl-30292819

ABSTRACT

With the high number of patients infected by tuberculosis and the sharp increase of drug-resistant tuberculosis cases, developing new drugs to fight this disease has become increasingly urgent. In this context, analogs of the naturally occurring enolphosphates Cyclipostins and Cyclophostin (CyC analogs) offer new therapeutic opportunities. The CyC analogs display potent activity both in vitro and in infected macrophages against several pathogenic mycobacteria including Mycobacterium tuberculosis and Mycobacterium abscessus. Interestingly, these CyC inhibitors target several enzymes with active-site serine or cysteine residues that play key roles in mycobacterial lipid and cell wall metabolism. Among them, TesA, a putative thioesterase involved in the synthesis of phthiocerol dimycocerosates (PDIMs) and phenolic glycolipids (PGLs), has been identified. These two lipids (PDIM and PGL) are non-covalently bound to the outer cell wall in several human pathogenic mycobacteria and are important virulence factors. Herein, we used biochemical and structural approaches to validate TesA as an effective pharmacological target of the CyC analogs. We confirmed both thioesterase and esterase activities of TesA, and showed that the most active inhibitor CyC17 binds covalently to the catalytic Ser104 residue leading to a total loss of enzyme activity. These data were supported by the X-ray structure, obtained at a 2.6-Å resolution, of a complex in which CyC17 is bound to TesA. Our study provides evidence that CyC17 inhibits the activity of TesA, thus paving the way to a new strategy for impairing the PDIM and PGL biosynthesis, potentially decreasing the virulence of associated mycobacterial species.


Subject(s)
Glycolipids/metabolism , Mycobacterium tuberculosis/enzymology , Organophosphorus Compounds/pharmacology , Thiolester Hydrolases/chemistry , Binding Sites , Catalytic Domain/drug effects , Cell Wall/metabolism , Crystallography, X-Ray , Enzyme Inhibitors , Lipids , Mycobacterium tuberculosis/chemistry , Thiolester Hydrolases/antagonists & inhibitors , Thiolester Hydrolases/metabolism , Virulence Factors/metabolism
12.
Small ; 14(24): e1801038, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29770993

ABSTRACT

Lithium cobalt oxide nanobatteries offer exciting prospects in the field of nonvolatile memories and neuromorphic circuits. However, the precise underlying resistive switching (RS) mechanism remains a matter of debate in two-terminal cells. Herein, intriguing results, obtained by secondary ion mass spectroscopy (SIMS) 3D imaging, clearly demonstrate that the RS mechanism corresponds to lithium migration toward the outside of the Lix CoO2 layer. These observations are very well correlated with the observed insulator-to-metal transition of the oxide. Besides, smaller device area experimentally yields much faster switching kinetics, which is qualitatively well accounted for by a simple numerical simulation. Write/erase endurance is also highly improved with downscaling - much further than the present cycling life of usual lithium-ion batteries. Hence very attractive possibilities can be envisaged for this class of materials in nanoelectronics.

13.
Curr Opin Struct Biol ; 49: 77-84, 2018 04.
Article in English | MEDLINE | ID: mdl-29414515

ABSTRACT

The Type VI secretion system (T6SS) is a dynamic nanomachine present in many Gram-negative bacteria. Using a contraction mechanism similar to that of myophages, bacteriocins or anti-feeding prophages, it injects toxic effectors into both eukaryotic and prokaryotic cells. T6SS assembles three large ensembles: the trans-membrane complex (TMC), the baseplate and the tail. Recently, the tail structure has been elucidated by cryo electron microscopy (cryoEM) in extended and contracted forms. The structure of the trans-membrane complex has been deciphered using a combination of X-ray crystallography and EM. However, the structural characterisation of the baseplate lags behind and should be the target of future studies. Finally, cryo-tomography should provide low/medium resolution maps allowing to assemble the different parts ultimately leading to a complete structural description of T6SS.


Subject(s)
Bacterial Proteins/chemistry , Gram-Negative Bacteria/chemistry , Type VI Secretion Systems/chemistry , Bacterial Proteins/ultrastructure , Cryoelectron Microscopy , Crystallography, X-Ray , Gram-Negative Bacteria/ultrastructure , Models, Molecular , Protein Conformation , Type VI Secretion Systems/ultrastructure
14.
Nat Microbiol ; 2: 17103, 2017 Jun 26.
Article in English | MEDLINE | ID: mdl-28650463

ABSTRACT

The type VI secretion system (T6SS) is a multiprotein machine widespread in Gram-negative bacteria that delivers toxins into both eukaryotic and prokaryotic cells. The mechanism of action of the T6SS is comparable to that of contractile myophages. The T6SS builds a tail-like structure made of an inner tube wrapped by a sheath, assembled under an extended conformation. Contraction of the sheath propels the inner tube towards the target cell. The T6SS tail is assembled on a platform-the baseplate-which is functionally similar to bacteriophage baseplates. In addition, the baseplate docks the tail to a trans-envelope membrane complex that orients the tail towards the target. Here, we report the crystal structure of TssK, a central component of the T6SS baseplate. We show that TssK is composed of three domains, and establish the contribution of each domain to the interaction with TssK partners. Importantly, this study reveals that the N-terminal domain of TssK is structurally homologous to the shoulder domain of phage receptor-binding proteins, and the C-terminal domain binds the membrane complex. We propose that TssK has conserved the domain of attachment to the virion particle but has evolved the reception domain to use the T6SS membrane complex as receptor.


Subject(s)
Bacteriophages/chemistry , Escherichia coli/chemistry , Type VI Secretion Systems/chemistry , Viral Proteins/chemistry , Bacteriophages/genetics , Bacteriophages/metabolism , Crystallization , Crystallography, X-Ray , Escherichia coli/metabolism , Membrane Proteins/metabolism , Models, Molecular , Protein Binding , Protein Domains , Protein Multimerization , Protein Transport , Receptors, Virus/metabolism , Type VI Secretion Systems/genetics , Type VI Secretion Systems/metabolism , Viral Proteins/genetics , Viral Proteins/metabolism
15.
Anticancer Agents Med Chem ; 17(1): 137-142, 2017.
Article in English | MEDLINE | ID: mdl-27039924

ABSTRACT

BACKGROUND: Prenyl flavonoid icaritin (1) and ß-anhydroicaritin (2) are two natural products with important biological and pharmacological effects. such as antiosteoporosis, estrogen regulation and antitumor properties. OBJECTIVE: The present study investigates the synthesis and cytotoxic activities on three Human cancer cell lines (Hela, HCC1954 and SK-OV-3) of icaritin and ß-anhydroicaritin Mannich base derivatives in vitro models. METHOD: Preylated flavonoid icaritin (1) upon treatment with formic acid under microwave assistance gave another natural product ß-anhydroicaritin (2) in good yield (89%). Based on Mannich reaction of 1 or 2 with various secondary amines and formaldehyde, two series eighteen new 6-aminomethylated flavonoids Mannich base derivatives 3-11 and 12-20 were synthesized. Their cytotoxic potential against three human cancer cell lines (Hela, HCC1954 and SK-OV-3) were evaluated by the standard MTT method with cis-Platin and Paclitaxel as positive control. RESULTS: Our research showed that most of these flavonoid Mannich base derivatives displayed equal or higher (lower IC50 values) cytotoxic activities than the positive control cis-Platin. Some compounds possess the IC50 value below 10µM. Compounds 6-(diisopropylamino)methyl- and 6-morpholinylmethyl substituted ß-anhydroicaritin (15 and 19) showed selective cytotoxicity against HCC1954 cells (IC50 12.688 µM) and Hela cells (IC50 6.543 µM) respectively. CONCLUSION: Our finding most of icaritin and ß-anhydroicaritin Mannich base derivatives possessing moderate to potent cytotoxicity against these three cancer cells (Hela, HCC1954 and SK-OV-3). Compound 15 and 19 showed selective cytotoxicity against HCC1954 cells and Hela cells respectively, they are potential and selective anticancer agent and worthy of further development.


Subject(s)
Antineoplastic Agents/pharmacology , Benzopyrans/pharmacology , Flavonoids/pharmacology , Mannich Bases/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Benzopyrans/chemical synthesis , Benzopyrans/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Flavonoids/chemical synthesis , Flavonoids/chemistry , Humans , Mannich Bases/chemical synthesis , Mannich Bases/chemistry , Neoplasms/drug therapy
16.
Mol Microbiol ; 99(6): 1099-118, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26714038

ABSTRACT

The Type VI secretion system (T6SS) is a multiprotein machine that delivers protein effectors in both prokaryotic and eukaryotic cells, allowing interbacterial competition and virulence. The mechanism of action of the T6SS requires the contraction of a sheath-like structure that propels a needle towards target cells, allowing the delivery of protein effectors. Here, we provide evidence that the entero-aggregative Escherichia coli Sci-1 T6SS is required to eliminate competitor bacteria. We further identify Tle1, a toxin effector encoded by this cluster and showed that Tle1 possesses phospholipase A1 and A2 activities required for the interbacterial competition. Self-protection of the attacker cell is secured by an outer membrane lipoprotein, Tli1, which binds Tle1 in a 1:1 stoichiometric ratio with nanomolar affinity, and inhibits its phospholipase activity. Tle1 is delivered into the periplasm of the prey cells using the VgrG1 needle spike protein as carrier. Further analyses demonstrate that the C-terminal extension domain of VgrG1, including a transthyretin-like domain, is responsible for the interaction with Tle1 and its subsequent delivery into target cells. Based on these results, we propose an additional mechanism of transport of T6SS effectors in which cognate effectors are selected by specific motifs located at the C-terminus of VgrG proteins.


Subject(s)
Escherichia coli/metabolism , Phospholipases A1/metabolism , Type VI Secretion Systems/metabolism , Animals , Bacterial Proteins/metabolism , Bacterial Toxins/genetics , Bacterial Toxins/metabolism , Caenorhabditis elegans , Escherichia coli/pathogenicity , Models, Molecular , Multigene Family , Phospholipases A1/chemistry , Phospholipases A1/genetics , Protein Domains , Type VI Secretion Systems/genetics , Virulence
17.
Acta Biochim Pol ; 62(3): 547-52, 2015.
Article in English | MEDLINE | ID: mdl-26345098

ABSTRACT

Kaempferide (3,5,7-trihydroxy-4'-methoxyflavone, 1), a naturally occurring flavonoid with potent anticancer activity in a number of human tumour cell lines, was first semisynthesized from naringin. Based on Mannich reaction of kaempferide with various secondary amines and formaldehyde, nine novel kaempferide Mannich base derivatives 2-10 were synthesized. The aminomethylation occurred preferentially in the position at C-6 and C-8 of the A-ring of kaempferide. All the synthetic compounds were tested for antiproliferative activity against three human cancer cell lines (Hela, HCC1954, SK-OV-3) by the standard MTT method. The results showed that compounds 1, 2 and 5-10 were more potent against Hela cells with IC50 values of 12.47-28.24 µM than the positive control cis-platin (IC50 41.25 µM), compounds 5, 6, 8 and 10 were more potent against HCC1954 cells with IC50 values of 8.82-14.97 µM than the positive control cis-platin (IC50 29.68 µM), and compounds 2, 3, 5, 6 and 10 were more potent against SK-OV-3 cells with IC50 values of 7.67-18.50 µM than the positive control cis-platin (IC50 21.27 µM).


Subject(s)
Antineoplastic Agents/chemistry , Drug Screening Assays, Antitumor/methods , Kaempferols/chemical synthesis , Mannich Bases/chemistry , Breast Neoplasms/pathology , Cell Line, Tumor/drug effects , Cell Proliferation , Cisplatin/chemistry , Dose-Response Relationship, Drug , Female , HeLa Cells , Humans , Inhibitory Concentration 50 , Kaempferols/pharmacology , Models, Chemical , Ovarian Neoplasms/pathology , Temperature , Uterine Cervical Neoplasms/pathology
18.
Nature ; 523(7562): 555-60, 2015 Jul 30.
Article in English | MEDLINE | ID: mdl-26200339

ABSTRACT

Bacteria share their ecological niches with other microbes. The bacterial type VI secretion system is one of the key players in microbial competition, as well as being an important virulence determinant during bacterial infections. It assembles a nano-crossbow-like structure in the cytoplasm of the attacker cell that propels an arrow made of a haemolysin co-regulated protein (Hcp) tube and a valine-glycine repeat protein G (VgrG) spike and punctures the prey's cell wall. The nano-crossbow is stably anchored to the cell envelope of the attacker by a membrane core complex. Here we show that this complex is assembled by the sequential addition of three type VI subunits (Tss)-TssJ, TssM and TssL-and present a structure of the fully assembled complex at 11.6 Å resolution, determined by negative-stain electron microscopy. With overall C5 symmetry, this 1.7-megadalton complex comprises a large base in the cytoplasm. It extends in the periplasm via ten arches to form a double-ring structure containing the carboxy-terminal domain of TssM (TssMct) and TssJ that is anchored in the outer membrane. The crystal structure of the TssMct-TssJ complex coupled to whole-cell accessibility studies suggest that large conformational changes induce transient pore formation in the outer membrane, allowing passage of the attacking Hcp tube/VgrG spike.


Subject(s)
Bacterial Secretion Systems , Escherichia coli Proteins/chemistry , Escherichia coli/chemistry , Lipopeptides/chemistry , Membrane Proteins/chemistry , Multiprotein Complexes/biosynthesis , Multiprotein Complexes/chemistry , Cell Membrane/chemistry , Cell Membrane/metabolism , Crystallography, X-Ray , Cytoplasm/chemistry , Cytoplasm/metabolism , Escherichia coli/metabolism , Escherichia coli Proteins/biosynthesis , Lipopeptides/biosynthesis , Membrane Proteins/biosynthesis , Microscopy, Electron , Models, Molecular , Periplasm/chemistry , Periplasm/metabolism , Porosity , Protein Structure, Tertiary , Protein Subunits/biosynthesis , Protein Subunits/chemistry
19.
Acta Crystallogr F Struct Biol Commun ; 71(Pt 3): 266-71, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25760699

ABSTRACT

The type VI secretion system (T6SS) is a machine evolved by Gram-negative bacteria to deliver toxin effectors into target bacterial or eukaryotic cells. The T6SS is functionally and structurally similar to the contractile tail of the Myoviridae family of bacteriophages and can be viewed as a syringe anchored to the bacterial membrane by a transenvelope complex. The membrane complex is composed of three proteins: the TssM and TssL inner membrane components and the TssJ outer membrane lipoprotein. The TssM protein is central as it interacts with both TssL and TssJ, therefore linking the membranes. Using controlled trypsinolysis, a 32.4 kDa C-terminal fragment of enteroaggregative Escherichia coli TssM (TssM32Ct) was purified. A nanobody obtained from llama immunization, nb25, exhibited subnanomolar affinity for TssM32Ct. Crystals of the TssM32Ct-nb25 complex were obtained and diffracted to 1.9 Šresolution. The crystals belonged to space group P64, with unit-cell parameters a = b = 95.23, c = 172.95 Å. Molecular replacement with a model nanobody indicated the presence of a dimer of TssM32Ct-nb25 in the asymmetric unit.


Subject(s)
Escherichia coli Proteins/chemistry , Escherichia coli/chemistry , Membrane Proteins/chemistry , Single-Domain Antibodies/chemistry , Amino Acid Sequence , Animals , Bacterial Secretion Systems/chemistry , Camelids, New World , Crystallization , Crystallography, X-Ray , Escherichia coli/metabolism , Escherichia coli Proteins/biosynthesis , Membrane Proteins/biosynthesis , Molecular Sequence Data , Peptide Fragments/chemistry
20.
PLoS One ; 10(3): e0122187, 2015.
Article in English | MEDLINE | ID: mdl-25811612

ABSTRACT

The type VI secretion system (T6SS) is a secretion pathway widespread in Gram-negative bacteria that targets toxins in both prokaryotic and eukaryotic cells. Although most T6SSs identified so far are involved in inter-bacterial competition, a few are directly required for full virulence of pathogens. The T6SS comprises 13 core proteins that assemble a large complex structurally and functionally similar to a phage contractile tail structure anchored to the cell envelope by a trans-membrane spanning stator. The central part of this stator, TssM, is a 1129-amino-acid protein anchored in the inner membrane that binds to the TssJ outer membrane lipoprotein. In this study, we have raised camelid antibodies against the purified TssM periplasmic domain. We report the crystal structure of two specific nanobodies that bind to TssM in the nanomolar range. Interestingly, the most potent nanobody, nb25, competes with the TssJ lipoprotein for TssM binding in vitro suggesting that TssJ and the nb25 CDR3 loop share the same TssM binding site or causes a steric hindrance preventing TssM-TssJ complex formation. Indeed, periplasmic production of the nanobodies displacing the TssM-TssJ interaction inhibits the T6SS function in vivo. This study illustrates the power of nanobodies to specifically target and inhibit bacterial secretion systems.


Subject(s)
Single-Domain Antibodies/pharmacology , Type VI Secretion Systems/antagonists & inhibitors , Amino Acid Sequence , Animals , Antibody Affinity , Antibody Specificity/immunology , Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Camelids, New World , Models, Molecular , Molecular Sequence Data , Protein Binding , Protein Conformation , Sequence Alignment , Single-Domain Antibodies/chemistry , Single-Domain Antibodies/immunology , Thermodynamics , Type VI Secretion Systems/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...